Literature DB >> 11730492

Labor induction for the preterm severe pre-eclamptic patient: is it worth the effort?

S C Blackwell1, M E Redman, M Tomlinson, J B Landwehr, M Tuynman, B Gonik, Y Sorokin, D B Cotton.   

Abstract

OBJECTIVE: The purpose of this study was to examine the success rate of labor induction in patients with severe pre-eclampsia delivered at < or = 34 weeks' gestation; to identify factors associated with its success; and to evaluate neonatal outcomes based on induction success or failure.
METHODS: We identified pregnancies complicated by severe pre-eclampsia delivered at < or = 34 weeks' at our institution from 1991 to 1998. Women who underwent labor induction and had successful vaginal delivery were compared to those who underwent labor induction, but required Cesarean delivery. Multiple logistic regression analyses were performed to assess factors associated with successful induction and neonatal outcome.
RESULTS: Over the 7-year study period, there were 215 patients meeting the criteria. Sixty-four (29.8%) did not undergo a labor attempt; 69 of 151 (46%) women who underwent labor induction achieved vaginal delivery. Labor induction was successful in 0%, 6.6%, 35.3% and 68.5% of cases at 24-26, 27-28, 29-31 and 32-34 weeks' gestation, respectively. By logistic regression the only factor positively associated with successful induction was gestational age at delivery (p = 0.001), while induction for non-reassuring fetal testing was inversely associated (p = 0.02). Induction attempt, failed induction and delivery mode were not associated with increased neonatal morbidity.
CONCLUSIONS: In women with severe pre-eclampsia remote from term, attempted labor induction did not appear to increase neonatal morbidity, but was rarely successful at < 28 weeks.

Entities:  

Mesh:

Year:  2001        PMID: 11730492     DOI: 10.1080/714904348

Source DB:  PubMed          Journal:  J Matern Fetal Med        ISSN: 1057-0802


  8 in total

1.  Success of labor induction for pre-eclampsia at preterm and term gestational ages.

Authors:  C Roland; C R Warshak; E A DeFranco
Journal:  J Perinatol       Date:  2017-03-30       Impact factor: 2.521

2.  Early preterm preeclampsia outcomes by intended mode of delivery.

Authors:  Elizabeth M Coviello; Sara N Iqbal; Katherine L Grantz; Chun-Chih Huang; Helain J Landy; Uma M Reddy
Journal:  Am J Obstet Gynecol       Date:  2018-09-28       Impact factor: 8.661

3.  Scheduled preterm delivery for gastroschisis improves postoperative outcome.

Authors:  Thomas Gelas; Daniela Gorduza; Simone Devonec; Pascal Gaucherand; Esther Downham; Olivier Claris; Rémi Dubois
Journal:  Pediatr Surg Int       Date:  2008-07-31       Impact factor: 1.827

Review 4.  Pre-eclampsia part 2: prediction, prevention and management.

Authors:  Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Steven J Korzeniewski; Lami Yeo; Roberto Romero
Journal:  Nat Rev Nephrol       Date:  2014-07-08       Impact factor: 28.314

5.  Maternal morbidity by attempted route of delivery in periviable birth.

Authors:  Tetsuya Kawakita; Tavor Sondheimer; Angie Jelin; Uma M Reddy; Helain J Landy; Chun-Chih Huang; Patrick S Ramsey; Michelle A Kominiarek; Katherine L Grantz
Journal:  J Matern Fetal Neonatal Med       Date:  2019-06-26

6.  Predicting factors for success of vaginal delivery in preterm induction with prostaglandin E2.

Authors:  Yoo Min Kim; Ju Young Park; Ji-Hee Sung; Suk-Joo Choi; Soo-Young Oh; Cheong-Rae Roh; Jong-Hwa Kim
Journal:  Obstet Gynecol Sci       Date:  2017-03-16

7.  A systematic scoping review of clinical indications for induction of labour.

Authors:  Dominiek Coates; Angela Makris; Christine Catling; Amanda Henry; Vanessa Scarf; Nicole Watts; Deborah Fox; Purshaiyna Thirukumar; Vincent Wong; Hamish Russell; Caroline Homer
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

8.  Cesarean birth in the Global Network for Women's and Children's Health Research: trends in utilization, risk factors, and subgroups with high cesarean birth rates.

Authors:  Margo S Harrison; Ana L Garces; Shivaprasad S Goudar; Sarah Saleem; Janet L Moore; Fabian Esamai; Archana B Patel; Elwyn Chomba; Carl L Bose; Edward A Liechty; Nancy F Krebs; Richard J Derman; Patricia L Hibberd; Waldemar A Carlo; Antoinette Tshefu; Marion Koso-Thomas; Elizabeth M McClure; Robert L Goldenberg
Journal:  Reprod Health       Date:  2020-12-17       Impact factor: 3.223

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.